Radhika Polisetty IDPharmD, FIDSA (@radhikaidpharmd) 's Twitter Profile
Radhika Polisetty IDPharmD, FIDSA

@radhikaidpharmd

@UK_COP grad, Associate Prof @MWUCCP, ID Pharmacist /Antibiotic Steward @Northwesternmed, Wife, Mom of 2 adorable kids, love to cook and travel. Tweets=own

ID: 2451919998

linkhttps://asp.nm.org/nmteam.html#CDH calendar_today18-04-2014 20:52:38

606 Tweet

639 Followers

555 Following

Cynthia Nguyen (@cynth_id) 's Twitter Profile Photo

Latest literature shows some pneumonias can be treated for as low as 3 days! @AlisonKLew reviews the literature. Have you incorporated this into your practice? #IDtwitter @TwitteRx

Latest literature shows some pneumonias can be treated for as low as 3 days! @AlisonKLew reviews the literature. Have you incorporated this into your practice? #IDtwitter @TwitteRx
SIDP (@sidpharm) 's Twitter Profile Photo

Don't miss out! Join us as we gear up for our #USAAW23 X chat hosted by SIDP, CDC Antimicrobial Resistance, SHEA, and ACCP INFD PRN! We'll discuss #antibiotic prescribing & #healthequity on November 14th at 8 pm ET! #ABXRxEquity

Don't miss out! Join us as we gear up for our #USAAW23 X chat hosted by <a href="/SIDPharm/">SIDP</a>, <a href="/CDC_AR/">CDC Antimicrobial Resistance</a>, <a href="/SHEA_Epi/">SHEA</a>, and <a href="/accpinfdprn/">ACCP INFD PRN</a>!

We'll discuss #antibiotic prescribing &amp; #healthequity on November 14th at 8 pm ET! #ABXRxEquity
Radhika Polisetty IDPharmD, FIDSA (@radhikaidpharmd) 's Twitter Profile Photo

Nice overview of treatment options and ongoing research for CRE isolates by Dr. Zachary Bulman winner of the ACCP 2023 New Investigator Award 👏🏼! Are we going back to the future with using AG for synergy ?😅 #ACCPAM23 ACCP INFD PRN

Nice overview of treatment options and ongoing research for CRE isolates by Dr. Zachary Bulman winner of the <a href="/ACCP/">ACCP</a> 2023 New Investigator Award 👏🏼! 
Are we going back to the future with using AG for synergy ?😅
#ACCPAM23 <a href="/accpinfdprn/">ACCP INFD PRN</a>
Clinical Infectious Diseases (@cidjournal) 's Twitter Profile Photo

IWGDF/IDSA Guidelines on the Diagnosis and Treatment of Diabetes-related Foot Infections (IWGDF/IDSA 2023) 🔓 Open Access bit.ly/3PGoNI7

Radhika Polisetty IDPharmD, FIDSA (@radhikaidpharmd) 's Twitter Profile Photo

Happening now! Join us for the ID PRN Focus session -Challenging the Dogma: Updates in Controversial Infectious Diseases Practices. #ACCPAM23

Happening now! Join us for the ID PRN Focus session -Challenging the Dogma: Updates in Controversial Infectious Diseases Practices. #ACCPAM23
SIDP (@sidpharm) 's Twitter Profile Photo

🆕 Episode of #Breakpoints! 😍 Drs. Bonomo, Ryan Shields, & Erin McCreary deep dive into the world of Metallo-β-lactamases. Covers nerdiest pub trivia nuggets & key details of novel therapies including beta-lactamase inhibitors & their role for MBLs 🎧 buff.ly/3OMKIwQ

🆕 Episode of #Breakpoints! 😍 
Drs. Bonomo, <a href="/ryankshields/">Ryan Shields</a>, &amp; <a href="/ErinMcCreary/">Erin McCreary</a> deep dive into the world of Metallo-β-lactamases. Covers nerdiest pub trivia nuggets &amp; key details of novel therapies including beta-lactamase inhibitors &amp; their role for MBLs

🎧 buff.ly/3OMKIwQ
SIDP (@sidpharm) 's Twitter Profile Photo

Don’t miss this one! Dr. Marc H. Scheetz presents insights into vanc dosing at ESCMID #ESCMIDGlobal2024! Trough conc resulted in misclassification of AUC category, with troughs <15 mg/L resulting in AUCs >400 mg*24h/L, trough conc did not precisely correlate w/ vanc AUCs 💉

Don’t miss this one! Dr. <a href="/IDPharmacometrx/">Marc H. Scheetz</a> presents insights into vanc dosing at <a href="/ESCMID/">ESCMID</a> #ESCMIDGlobal2024! Trough conc resulted in misclassification of AUC category, with troughs &lt;15 mg/L resulting in AUCs &gt;400 mg*24h/L, trough conc did not precisely correlate w/ vanc AUCs 💉
ACCP INFD PRN (@accpinfdprn) 's Twitter Profile Photo

✈️Planning your ACCP Annual Meeting Itinerary? Don't miss the #IDPRN Focus Session w/ this 🤩🌟 line-up! Agenda: new agents for MDR GN infxn, new vaccine considerations, and new antifungals! 📰 #ACCPAnnualMeeting2024 🗓️: 10/14 3:30PM-5PM MST 🏢: N. Building/N. Ballroom 120A

✈️Planning your ACCP Annual Meeting Itinerary? Don't miss the #IDPRN Focus Session w/ this 🤩🌟 line-up! Agenda: new agents for MDR GN infxn, new vaccine considerations, and new antifungals! 📰
#ACCPAnnualMeeting2024
🗓️: 10/14 3:30PM-5PM MST
🏢: N. Building/N. Ballroom 120A
Illinois IHSI (@illinoisihsi) 's Twitter Profile Photo

#Illinois students interested in biomedical research are invited to apply to pre-selection for Mayo Clinic's SURF program. Learn more about Illinois' special pre-selection process, hear from past SURFs & ask questions at an info session Oct. 10. Details: go.illinois.edu/MayoILSURF

#Illinois students interested in biomedical research are invited to apply to pre-selection for
<a href="/MayoClinic/">Mayo Clinic</a>'s SURF program.

Learn more about Illinois' special pre-selection process, hear from past SURFs &amp; ask questions at an info session Oct. 10. 
Details: go.illinois.edu/MayoILSURF
Justin Moore (@moore_wjustin) 's Twitter Profile Photo

Terrific ACCP INFD PRN Focused session at ACCP #ACCPAM24 from Drs. Ashlan J. Kunz Coyne, Emily, Radhika Polisetty IDPharmD, FIDSA, & Jessica Leininger! Covered new BL/BLI therapies for MDR Gram negatives, RSV & Strep pneumo vaccines, & novel antifungals! 💊

Terrific <a href="/accpinfdprn/">ACCP INFD PRN</a> Focused session at <a href="/ACCP/">ACCP</a> #ACCPAM24 from Drs. <a href="/Ashlan_Kunz/">Ashlan J. Kunz Coyne</a>, <a href="/EmDrwiega/">Emily</a>, <a href="/RadhikaIdpharmd/">Radhika Polisetty IDPharmD, FIDSA</a>, &amp; Jessica Leininger!

Covered new BL/BLI therapies for MDR Gram negatives, RSV &amp; Strep pneumo vaccines, &amp; novel antifungals! 💊
SIDP (@sidpharm) 's Twitter Profile Photo

Visit poster 1740 today to see @littlebugdrug & discuss her study “Education, in the hands of pharmacists, can flip the curve! Empiric CFZ went from 35% ➡️ 80% compared to CRO for UTI txp”. #IDWEEK2024 #SIDP2024 @doxyfloxacin Justin Moore Radhika Polisetty IDPharmD, FIDSA Jim Rhodes (8/8)

Visit poster 1740 today to see @littlebugdrug &amp; discuss her study “Education, in the hands of pharmacists, can flip the curve! Empiric CFZ went from 35% ➡️ 80% compared to CRO for UTI txp”. #IDWEEK2024 #SIDP2024 @doxyfloxacin <a href="/moore_wjustin/">Justin Moore</a> <a href="/RadhikaIdpharmd/">Radhika Polisetty IDPharmD, FIDSA</a> <a href="/njrhodes_rx/">Jim Rhodes</a> (8/8)
Radhika Polisetty IDPharmD, FIDSA (@radhikaidpharmd) 's Twitter Profile Photo

Please check out this poster by Rahul Garg my SIDP Mentee! Grateful for this opportunity to learn about challenges facing AS in India and share resources. Thank you IDSA for the Trainee Travel Award. #IDWeek2024 #SIDP2024

Please check out this poster by <a href="/RahulGarg_89/">Rahul Garg</a> my <a href="/SIDPharm/">SIDP</a> Mentee! Grateful for this opportunity to learn about challenges facing AS in India and share resources. Thank you <a href="/IDSAInfo/">IDSA</a> for the Trainee Travel Award. #IDWeek2024 #SIDP2024
Midwestern University (@midwesternuniv) 's Twitter Profile Photo

Proud of our own Dr. Marc H. Scheetz Marc H. Scheetz in our MWU College of Pharmacy! His recent paper on Global Guidelines for Extended IV Antibiotic Use has become the most downloaded article in Pharmacotherapy over the past two years. Way to represent MWU!

Proud of our own Dr. Marc H. Scheetz <a href="/idpharmacometrx/">Marc H. Scheetz</a> in our <a href="/mwupharmacy/">MWU College of Pharmacy</a>! His recent paper on Global Guidelines for Extended IV Antibiotic Use has become the most downloaded article in Pharmacotherapy over the past two years. Way to represent MWU!
Julie Ann Justo (@julie_justo) 's Twitter Profile Photo

🚨Wow. Big news. First oral carbapenem, sulopenem (plus probenecid), just approved by the FDA for uUTI. 💊 Bring out the popcorn 🍿 This is gonna be interesting…. #IDtwitter SIDP ACCP INFD PRN IDSA globenewswire.com/news-release/2…